MedTrace Logo

Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate

NCT01955369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-05-19

Study results available
· View outcomes & findings →

Summary

There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.

Conditions

Sponsors & Collaborators

  • Klinikum Ludwigshafen

    lead OTHER

Principal Investigators

  • Joachim Wolf, Dr · Dept. Neurology, Klinikum Ludwigshafen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-09-30
Completion
2015-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01955369 on ClinicalTrials.gov